Contraline Secures $92.5M to Push Its Male Birth Control Candidates Forward
Contraline raised $92.5 million in new funding to advance its two male contraceptive candidates, including a once-daily topical gel and an implantable option.
GoodRx Expands Women’s Health Options with New Birth Control and Menopause Offerings
GoodRx announced a new e-commerce solution starting with over-the-counter birth control pill Opill. It also is offering new affordability programs for menopause medications with Pfizer.
presented by
Inside an Automated Healthcare Practice: Redesigning Care Around People, Not Paperwork
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
The Future of Birth Control: No Hormones, More Options for Men
The advancement, adoption of, and access to these options – regardless of age, geography, and financial considerations – requires the support of the scientific community, drug developers, funders, regulatory agencies, insurers, and lawmakers to make the concept of a hormone-free future a reality.
Trial Data Looks Promising for ‘IUD For Men’
Contraline released promising data from the clinical trial it’s conducting to test the efficacy of Adam, its male birth control product. The nonhormonal gel seems to be doing a good job of blocking the flow of sperm to the vas deferens, and no serious adverse events have been reported.
48 Senators Urge Biden Administration To Mandate Coverage of OTC Contraceptives
Several senators wrote a letter to the Biden Administration asking for action that ensures coverage of over-the-counter birth control without the need for a prescription. The letter was led by Senators Patty Murray (D-Washington), Tammy Baldwin (D-Wisconsin), Bernie Sanders (I-Vermont) and Ron Wyden (D-Oregon).
Introducing MedCity FemFwd, a New Podcast on Women’s Health
MedCity News is launching a new podcast called MedCity FemFwd, which will discuss the breakthroughs and challenges in the women's health space. In the inaugural episode, Michelle Long of KFF examines whether Opill — the first daily oral contraceptive approved for nonprescription use in the U.S. — will be covered by insurance.
presented by
Top 7 Modern AI-Powered EAP Providers for Global Workforces in 2026
Discover the top AI-powered EAP providers for 2026. Compare platforms like Kyan Health and Spring Health on triage speed, global reach, and clinical quality to transform workforce wellbeing.
FDA Nod Makes Perrigo’s Opill the First Oral Contraceptive to Switch to OTC Use
FDA approval of Opill makes it the first oral contraceptive that may be used without a prescription. Clinicians say over-the-counter availability will lower barriers to access to a key component of reproductive healthcare.
KFF: 77% of Women Are In Favor of Over-the-counter Birth Control Pills
The main factor behind why women want over-the-counter birth control pills is convenience, the survey found. Of those who are unlikely to use over-the-counter birth control pills — or are unsure if they would —most said it's because they don’t currently use birth control pills or don’t plan to in the future.
House report finds PBMs and insurers aren’t covering birth control like ACA requires
The investigation also found that companies denied exceptions requests on average four or more times out of ten, raising barriers to accessing birth control, according to a news release on Tuesday.
HeyDoctor’s telemedicine app lets physicians prescribe via text
San Francisco-based HeyDoctor has released a new app that enables providers to prescribe certain treatments through text messaging. Its services currently include everything from acne diagnosis to UTI testing to smoking cessation.
The Power of Real World Data to Study Women’s Health at Scale
Veradigm examines key clinical trends, comorbidity profiles, and treatment trends across adolescence, reproductive years, and peri-/post-menopause. Download it today!
Trump adds exemption so that non religious employers can avoid providing birth control coverage
The exemption is for “non-religious organizations with sincerely held moral convictions inconsistent with providing coverage for some or all contraceptive services.”
Is sexism a factor in decision to stop trial of male birth control?
Some ethicists and advocates say it represents a double standard, citing evidence that female contraception also may be related to depression and other side effects. They argue men are being protected from the same unpleasant consequences that women are forced to accept.
Cases continue against Bayer’s Essure birth control device, based on a ruling from a federal judge
Bayer previously asked that the lawsuit be dismissed - but John Padova, U.S. District Judge in Philadelphia, has ruled that claims made by two particular women signify legitimate misleading advertising, essentially failing to provide information about certain risks.
Oregon follows California and allows pharmacists to prescribe birth control
California and Oregon are the only two states in the country that now allow pharmacists to prescribe birth control to women without consulting a doctor first.
Do health policy wonks love their IUDs? Twitter investigates
The subject of IUDs might be controversial to some, but those in the healthcare field are having an open conversation.